26 Sep 2025 | 3 Mins Read
Zydus Lifesciences slides 2.97% with heavy trading
Flipitmoney
Shares of Zydus Lifesciences were trading lower on Friday, with the stock priced at Rs 989, a decline of 2.97%, making it among the top losers on the Nifty Next 50 index. The company's revenue for the year-ending March 2025 was Rs 23,241.50 Crore, with a net profit of Rs 4,614.80 Crore. EPS was 44.97.